一名患有20年慢性髓性白血病的患者在首次分子反应时发生JAK2 V617F突变的真性红细胞增多症。 - Suppr

JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.

作者信息

Tosoni Luca, Fabbro Dora, Pizzano Umberto, Mullai Rikard, Morelli Gianluca, Franzoni Alessandra, Damante Giuseppe, Toffoletti Eleonora, Damiani Daniela, Fanin Renato, Tiribelli Mario

机构信息

Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, P.Le S. M. Misericordia 15, 33100, Udine, Italy.

Institute of Medical Genetics, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

出版信息

Ann Hematol. 2023 May;102(5):1279-1280. doi: 10.1007/s00277-023-05187-5. Epub 2023 Mar 22.

DOI:10.1007/s00277-023-05187-5

PMID:36947213

Abstract

摘要

相似文献

JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.一名患有20年慢性髓性白血病的患者在首次分子反应时发生JAK2 V617F突变的真性红细胞增多症。

Ann Hematol. 2023 May;102(5):1279-1280. doi: 10.1007/s00277-023-05187-5. Epub 2023 Mar 22.

Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.评论：在首次分子反应时，一名患有20年慢性髓性白血病的患者发生JAK2 V617F突变的真性红细胞增多症。

Ann Hematol. 2023 Sep;102(9):2619-2620. doi: 10.1007/s00277-023-05297-0. Epub 2023 May 31.

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders.一名同时患有真性红细胞增多症和慢性髓性白血病的患者：两种疾病的动态变化。

Int J Hematol. 2010 Jan;91(1):136-9. doi: 10.1007/s12185-009-0471-6. Epub 2010 Jan 5.

Transformation of polycythemia vera to chronic myelogenous leukemia.真性红细胞增多症转化为慢性粒细胞白血病。

Arch Pathol Lab Med. 2007 Nov;131(11):1719-24. doi: 10.5858/2007-131-1719-TOPVTC.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.Janus激酶2 V617F突变在肿瘤性髓系疾病脾脏髓外造血中的作用。

Mod Pathol. 2007 Sep;20(9):929-35. doi: 10.1038/modpathol.3800826. Epub 2007 Jul 20.

Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib.用芦可替尼和达沙替尼治疗的JAK2 V617F阳性真性红细胞增多症与BCR-ABL阳性慢性粒细胞白血病并存病例

Blood Cancer J. 2015 Oct 2;5(10):e351. doi: 10.1038/bcj.2015.77.

The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.LNK基因多态性与骨髓增殖性肿瘤临床类型相关

PLoS One. 2016 Apr 25;11(4):e0154183. doi: 10.1371/journal.pone.0154183. eCollection 2016.

Molecular genetic evaluation of myeloproliferative neoplasms.骨髓增殖性肿瘤的分子遗传学评估

Int J Lab Hematol. 2015 May;37 Suppl 1:61-71. doi: 10.1111/ijlh.12353.

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.JAK2V617F阳性真性红细胞增多症和费城染色体阳性慢性髓性白血病：一例患有两种不同骨髓增殖性疾病的患者。

Leukemia. 2008 Jul;22(7):1454-5. doi: 10.1038/sj.leu.2405088. Epub 2008 Feb 21.

JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera.携带JAK2 V617F突变的原发性血小板增多症患者表现出真性红细胞增多症的临床特征。

Leuk Lymphoma. 2008 Apr;49(4):696-9. doi: 10.1080/10428190701885537.

引用本文的文献

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.同时存在JAK2 V617F和BCR::ABL1的患者的临床、形态学和遗传学特征

Sci Rep. 2025 Jul 18;15(1):26046. doi: 10.1038/s41598-025-11096-6.

Co-occurrence of mutation and translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.慢性骨髓增殖性肿瘤中突变与易位的同时出现：一种潜在的混淆性基因组合。

Front Oncol. 2024 Jan 12;13:1329298. doi: 10.3389/fonc.2023.1329298. eCollection 2023.

Ann Hematol. 2023 Sep;102(9):2619-2620. doi: 10.1007/s00277-023-05297-0. Epub 2023 May 31.

本文引用的文献

Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature.并发JAK2阳性骨髓增殖性疾病和慢性粒细胞白血病：一种新的实体？一例病例报告并文献复习

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832322. doi: 10.1177/2324709619832322.

Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.骨髓增殖性肿瘤中并存的驱动基因突变：11例患者系列的临床和分子特征

Hematology. 2018 Dec;23(10):785-792. doi: 10.1080/10245332.2018.1498182. Epub 2018 Jul 11.

Myeloproliferative neoplasms: from origins to outcomes.骨髓增殖性肿瘤：从起源到结局。

Blood. 2017 Dec 7;130(23):2475-2483. doi: 10.1182/blood-2017-06-782037.

Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone.一名携带JAK2V617F突变的患者出现BCR-ABL易位：JAK2V617F克隆中继发性获得BCR-ABL的证据。

J Clin Oncol. 2014 Jul 20;32(21):e76-9. doi: 10.1200/JCO.2012.47.8669. Epub 2014 Feb 10.

BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia.在真性红细胞增多症患者发展为慢性髓性白血病的过程中，BCR-ABL1是JAK2V617F之后的继发事件。

Blood. 2013 Feb 14;121(7):1238-9. doi: 10.1182/blood-2012-11-467787.

Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia.伊马替尼治疗后慢性粒细胞白血病患者出现新的JAK2V617F克隆并随后发展为明显的真性红细胞增多症。

Eur J Haematol. 2010 Jul;85(1):86-7. doi: 10.1111/j.1600-0609.2010.01458.x. Epub 2010 Apr 16.

A case of coexistence between JAK2V617F and BCR /ABL.一例JAK2V617F与BCR/ABL共存的病例。

Eur J Haematol. 2008 Jul;81(1):75-6. doi: 10.1111/j.1600-0609.2008.01063.x. Epub 2008 Mar 10.

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.一名费城染色体阳性慢性髓性白血病患者的JAK2-V617F突变

Lancet Oncol. 2007 Jul;8(7):658-60. doi: 10.1016/S1470-2045(07)70206-1.

Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia.与JAK2V617F突变相关的红细胞增多症在慢性粒细胞白血病治疗期间出现。

Leukemia. 2007 May;21(5):1103-4. doi: 10.1038/sj.leu.2404591. Epub 2007 Feb 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献